Clinical Trial Update: A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors [Phase 1]

View source ↗

Summary

This first-in-human Phase 1 trial update reports ALX2004 for advanced or metastatic solid tumors and notes that the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Squamous Cell Carcinoma
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• ALX2004

Snippet

Sponsor: ALX Oncology Inc. | Conditions: NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC | Phase 1 | Status: RECRUITING